JPJ. Regino Perez-Polo

J. Regino Perez-Polo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


J. Regino Perez-Polo has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • David K. Rassin

    Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA

    4 shared publications
  • Jingxin Qiu

    Human Biological Chemistry and Genetics

    2 shared publications
  • Michael Edwards

    Department of Human Biological Chemistry and Genetics, The University of Texas Medical Branch at Galveston, Galveston, Texas

    2 shared publications
  • Tracy Toliver‐Kinsky

    Department of Human Biological Chemistry and Genetics, The University of Texas Medical Branch at Galveston, Galveston, Texas

    2 shared publications
  • Xiaoming Hu

    Department of Anatomy and Neuroscience, University of Texas Medical Branch, Galveston, Texas, USA

    2 shared publications
  • Gitta Wörtwein

    Laboratory of Neuropsychiatry, Psychiatric Centre Copenhagen, Rigshospitalet, 2100, Copenhagen, Denmark; Department of Public Health, University of Copenhagen, 1014, Copenhagen, Denmark

    1 shared publication

Latest Publications

  • Bax shuttling after neonatal hypoxia-ischemia: Hyperoxia effects

    by Martin B. Gill, Kurt Bockhorst, Ponnada Narayana, J. Regino Perez-Polo


  • Down‐regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease‐relevant genes and proteins

    by Thole Zuchner, Reinhard Schliebs, J. Regino Perez‐Polo

    Beta-amyloid peptides play a major role in the pathogenesis of Alzheimer's disease (AD). Therefore, preventing beta-amyloid formation by inhibition of the beta site amyloid precursor protein-cleaving enzyme (BACE) 1 is considered as a potential strategy to treat AD. Cholinergic mechanisms have been shown to control amyloid precursor protein processing and the number of muscarinic M2-acetylcholine receptors is decreased in brain regions of patients with AD enriched with senile plaques. Therefore, the present study investigates the effect of this M2 muscarinic receptor down-regulation by siRNA on total gene expression and on regulation of BACE1 in particular in SK-SH-SY5Y cells. This model system was used for microarray analysis after carbachol stimulation of siRNA-treated cells compared with carbachol stimulated, non-siRNA-treated cells. The same model system was used to elucidate changes at the protein level by using two-dimensional gels followed by Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF) analysis. Taken together, the results indicate that the M2 acetylcholine receptor down-regulation in brains of patients with AD has important effects on the expression of several genes and proteins with major functions in the pathology of AD. This includes beta-secretase BACE1 as well as several modulators of the tau protein and other AD-relevant genes and proteins. Moreover, most of these genes and proteins are adversely affected against the background of AD.


  • Open Access

    Activation of nuclear factor‐κB signaling pathway by interleukin‐1 after hypoxia/ischemia in neonatal rat hippocampus and cortex

    by Xiaoming Hu, Olivera Nesic‐Taylor, Jingxin Qiu, Harriett C. Rea, Roderick Fabian, David K. Rassin, J. Regino Perez‐Polo

    Perinatal hypoxia/ischemia (HI) is a common cause of neurological deficits in children. Interleukin‐1 (IL‐1) activity has been implicated in HI‐induced brain damage. However, the mechanisms underlying its action in HI have not been characterized. We used a 7‐day‐old rat model to elucidate the role of nuclear factor‐κB (NF‐κB) activation in HI stimulation of IL‐1 signaling. HI was induced by permanent ligation of the left carotid artery followed by 90 min of hypoxia (7.8% O2). Using ELISA assays, we observed increased cell death and caspase 3 activity in hippocampus and cortex 3, 6, 12, 24 and 48 h post‐HI. IL‐1β protein expression increased, beginning at 3 h after HI and lasting until 24 h post‐HI in hippocampus and 12 h post‐HI in cortex. Intracerebroventricular injection of 2µg IL‐1 receptor antagonist (IL‐1Ra) 2 h after HI significantly reduced cell death and caspase 3 activity. Electrophoretic mobility shift assay analyses of hippocampus and cortex after HI for NF‐κB activity showed increased p65/p50 DNA‐binding activity at 24 h post‐HI. Western blot analyses showed significant nuclear translocation of p65. Protein expression levels of two known inflammatory agents, inducible nitric oxide synthase and cycloxygenase 2, known to be transcriptionally regulated by NF‐κB, also increased at 24 h after HI. All these HI‐induced changes were reversed by IL‐1Ra blockade of IL‐1 signaling, consistent with IL‐1 triggering of inflammatory apoptotic outcomes via NF‐κB transcriptional activation. The observed increase in cytoplasmic phosphorylated inhibitor κBα (IκBα) and nuclear translocation of Bcl‐3 24 h after HI was also significantly attenuated by IL‐1Ra blockade, suggesting that HI‐induced IL‐1 activation of NF‐κB is via both the degradation of IκBα and the nuclear translocation of Bcl‐3.


  • Effects of NF‐κB oligonucleotide “Decoys” on gene expression in P7 rat hippocampus after hypoxia/ischemia

    by Jingxin Qiu, Xiaoming Hu, Olivera Nesic, Marjorie R. Grafe, David K. Rassin, Thomas G. Wood, J. Regino Perez‐Polo

    “Decoy” oligonucleotides can be used as gene‐specific nuclear factor (NF‐κB) inhibitors to regulate gene expression. We applied two different decoy oligonucleotides that contained the NF‐κB binding consensus sequences present in the immunoglobulin G (IgG)‐κB and Bcl‐x promoter into 7‐day‐old (P7) rat lateral ventricles before hypoxia/ischemia (HI) and compared their effects on gene expression in hippocampi to saline‐treated, scrambled decoy‐treated, or untreated hippocampi exposed to HI. Left hippocampi were collected at 12 hr after HI. Electrophoretic mobility shift assays (EMSAs) showed that the two decoy treatments had different effects on NF‐κB binding to the IgG‐κB and Bcl‐x promoter‐specific consensus sequences, respectively. We assessed the decoys' effects on gene expression 12 hr after HI using ribonuclease protection assays (RPAs) and Affymetrix DNA microarrays. RPAs showed that both decoys significantly decreased interleukin (IL)‐1α mRNA levels but had no impact on IL‐1β, IL‐6, and IL‐10 mRNA levels. IgG‐κB decoys significantly decreased tumor necrosis factor (TNF)‐α and TNF‐β mRNA levels compared to minimal changes after treatment with Bcl‐x decoys. DNA microarray analyses showed that Bcl‐x decoy treatment significantly decreased Bcl‐xL mRNA levels. The decreased Bcl‐xL mRNA levels after Bcl‐x decoy treatment was confirmed by RPA analysis. DNA microarray data also indicated that several other genes were affected by both decoys. Our results suggest that different NF‐κB decoy treatments could differentially regulate transcriptional responses to central nervous system trauma. Careful design of decoy sequences, however, is essential to acquire selective effects on cell death outcome.


  • Open Access

    Attenuated transcriptional responses to oxidative stress in the aged rat brain

    by LiQi Tong, Tracy Toliver‐Kinsky, Michael Edwards, David K. Rassin, Karin Werrbach‐Perez, J. Regino Perez‐Polo

    The aged nervous system displays impaired cognitive functions, and these impairments are exacerbated in several neurodegenerative diseases. A role for oxidative stress has been suggested for several of these age‐associated dysfunctions. In addition, recovery from more acute traumatic insults that also generate oxidative stress is impaired in the aged. Here we examine the response of aged rat hippocampi to normobaric hyperoxia treatments and demonstrate an attenuation in the DNA binding activity of the AP‐1 and nuclear factor‐κB transcription factors, which are important components of stress response signal transduction pathways and can determine shifts in cellular commitments to necrosis, apoptosis, or functional recovery in the central nervous system.


  • Poly(ADP‐ribose) polymerase inhibition prevents both apoptotic‐like delayed neuronal death and necrosis after H2O2 injury

    by Kasie K. Cole, J. Regino Perez‐Polo

    Toxic reactive oxygen species (ROS) such as hydrogen peroxide, nitric oxide, superoxide, and the hydroxyl radical are generated in a variety of neuropathological conditions and cause significant DNA damage. We determined the effects of 3‐aminobenzamide (AB), an inhibitor of the DNA repair enzyme poly(ADP‐ribose) polymerase (PARP), on cell death in differentiated PC12 cells, a model of sympathetic neurons, after H2O2 injury. Exposure to 0.5 mm H2O2 resulted in a significant decrease in intracellular NAD(H), NADP(H), and ATP levels. This injury resulted in the death of 90% of the cells with significant necrosis early (2 h) after injury and increased apoptosis (12–24 h after injury), as measured by PS exposure and the presence of cytoplasmic oligonucleosomal fragments. Treatment with 2.5 mm AB restored pyridine nucleotide and ATP levels and ameliorated cell death (65% versus 90%) by decreasing the extent of both necrosis and apoptosis. Interestingly, we observed that H2O2‐induced injury caused a delayed cell death exhibiting features of apoptosis but in which caspase‐3 like activity was absent. Moreover, pretreatment with AB restored caspase‐3‐like activity. Our results suggest that apoptosis and necrosis are both triggered by PARP overactivation, and that maintenance of cellular energy levels after injury by inhibiting PARP shifts cell death from necrosis to apoptosis.


  • APE/Ref‐1 responses to oxidative stress in aged rats

    by Michael Edwards, David K. Rassin, Tadahide Izumi, Sankar Mitra, J. Regino Perez‐Polo